Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078390838> ?p ?o ?g. }
- W2078390838 endingPage "793" @default.
- W2078390838 startingPage "789" @default.
- W2078390838 abstract "Fatigue, sexual dysfunction, anxiety and depression are all more common in patients who have previously been treated with cytotoxic chemotherapy and radiotherapy (XRT) for haematological malignancies. Following therapy, a significant proportion of men have biochemical evidence of Leydig cell dysfunction, defined by a raised luteinizing hormone level in the presence of a low/normal testosterone level. We postulated that mild testosterone deficiency may account for some of the long-term side-effects of treatment, and we have therefore assessed fatigue, mood and sexual function by questionnaire in 36 patients with Leydig cell dysfunction (group 1), and also in a group of 30 patients (group 2) with normal hormone levels who underwent the same treatment for cancer. There was no significant difference in anxiety and depression scores between the two groups although anxiety scores were higher than those previously reported for normal men. Eighty-seven per cent of group 2 were sexually active compared with only 69% of group 1 (P= 0.1), and patients in group 1 engaged less in sexual activity than those in group 2 (mean of 1.8 times per week compared with 3.2 times per week; P = 0.02) Fatigue scores were significantly higher in both groups compared with normal men, but there were no significant differences in any of the fatigue subscales between the two groups. We conclude that mild Leydig cell insufficiency following treatment with cytotoxic chemotherapy +/- XRT is not associated with higher levels of fatigue and anxiety but may result in reduced sexual function. These results do not provide a convincing argument that androgen replacement therapy is mandatory to improve quality of life in the majority of these patients, although it may be beneficial in a minority. To establish criteria for selection of patients for a trial of androgen therapy a randomized placebo-controlled study will be necessary." @default.
- W2078390838 created "2016-06-24" @default.
- W2078390838 creator A5008225174 @default.
- W2078390838 creator A5009024812 @default.
- W2078390838 creator A5009497247 @default.
- W2078390838 creator A5011398209 @default.
- W2078390838 date "2000-02-01" @default.
- W2078390838 modified "2023-10-06" @default.
- W2078390838 title "Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction" @default.
- W2078390838 cites W1537046417 @default.
- W2078390838 cites W1845447069 @default.
- W2078390838 cites W1958106252 @default.
- W2078390838 cites W1967708800 @default.
- W2078390838 cites W1969846494 @default.
- W2078390838 cites W1995358795 @default.
- W2078390838 cites W1995724573 @default.
- W2078390838 cites W2002177996 @default.
- W2078390838 cites W2012494940 @default.
- W2078390838 cites W2018023326 @default.
- W2078390838 cites W2023704549 @default.
- W2078390838 cites W2024893953 @default.
- W2078390838 cites W2046911659 @default.
- W2078390838 cites W2048926864 @default.
- W2078390838 cites W2059454393 @default.
- W2078390838 cites W2076557271 @default.
- W2078390838 cites W2085042736 @default.
- W2078390838 cites W2085424111 @default.
- W2078390838 cites W2100014097 @default.
- W2078390838 cites W2122279042 @default.
- W2078390838 cites W2159850384 @default.
- W2078390838 cites W2161488267 @default.
- W2078390838 cites W2166281097 @default.
- W2078390838 cites W2166327326 @default.
- W2078390838 cites W2269332409 @default.
- W2078390838 doi "https://doi.org/10.1054/bjoc.1999.1000" @default.
- W2078390838 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2374403" @default.
- W2078390838 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10732747" @default.
- W2078390838 hasPublicationYear "2000" @default.
- W2078390838 type Work @default.
- W2078390838 sameAs 2078390838 @default.
- W2078390838 citedByCount "88" @default.
- W2078390838 countsByYear W20783908382012 @default.
- W2078390838 countsByYear W20783908382013 @default.
- W2078390838 countsByYear W20783908382014 @default.
- W2078390838 countsByYear W20783908382015 @default.
- W2078390838 countsByYear W20783908382016 @default.
- W2078390838 countsByYear W20783908382017 @default.
- W2078390838 countsByYear W20783908382018 @default.
- W2078390838 countsByYear W20783908382019 @default.
- W2078390838 countsByYear W20783908382020 @default.
- W2078390838 countsByYear W20783908382021 @default.
- W2078390838 countsByYear W20783908382022 @default.
- W2078390838 countsByYear W20783908382023 @default.
- W2078390838 crossrefType "journal-article" @default.
- W2078390838 hasAuthorship W2078390838A5008225174 @default.
- W2078390838 hasAuthorship W2078390838A5009024812 @default.
- W2078390838 hasAuthorship W2078390838A5009497247 @default.
- W2078390838 hasAuthorship W2078390838A5011398209 @default.
- W2078390838 hasBestOaLocation W20783908381 @default.
- W2078390838 hasConcept C118552586 @default.
- W2078390838 hasConcept C126322002 @default.
- W2078390838 hasConcept C134018914 @default.
- W2078390838 hasConcept C139719470 @default.
- W2078390838 hasConcept C162324750 @default.
- W2078390838 hasConcept C2775871022 @default.
- W2078390838 hasConcept C2776694085 @default.
- W2078390838 hasConcept C2776867660 @default.
- W2078390838 hasConcept C2777736315 @default.
- W2078390838 hasConcept C2778093883 @default.
- W2078390838 hasConcept C2778575703 @default.
- W2078390838 hasConcept C2779279991 @default.
- W2078390838 hasConcept C2780733359 @default.
- W2078390838 hasConcept C558461103 @default.
- W2078390838 hasConcept C71315377 @default.
- W2078390838 hasConcept C71924100 @default.
- W2078390838 hasConceptScore W2078390838C118552586 @default.
- W2078390838 hasConceptScore W2078390838C126322002 @default.
- W2078390838 hasConceptScore W2078390838C134018914 @default.
- W2078390838 hasConceptScore W2078390838C139719470 @default.
- W2078390838 hasConceptScore W2078390838C162324750 @default.
- W2078390838 hasConceptScore W2078390838C2775871022 @default.
- W2078390838 hasConceptScore W2078390838C2776694085 @default.
- W2078390838 hasConceptScore W2078390838C2776867660 @default.
- W2078390838 hasConceptScore W2078390838C2777736315 @default.
- W2078390838 hasConceptScore W2078390838C2778093883 @default.
- W2078390838 hasConceptScore W2078390838C2778575703 @default.
- W2078390838 hasConceptScore W2078390838C2779279991 @default.
- W2078390838 hasConceptScore W2078390838C2780733359 @default.
- W2078390838 hasConceptScore W2078390838C558461103 @default.
- W2078390838 hasConceptScore W2078390838C71315377 @default.
- W2078390838 hasConceptScore W2078390838C71924100 @default.
- W2078390838 hasIssue "4" @default.
- W2078390838 hasLocation W20783908381 @default.
- W2078390838 hasLocation W20783908382 @default.
- W2078390838 hasLocation W20783908383 @default.
- W2078390838 hasLocation W20783908384 @default.
- W2078390838 hasOpenAccess W2078390838 @default.
- W2078390838 hasPrimaryLocation W20783908381 @default.